Digitisation | April 17, 2026
Kayentis and RWS partner to improve clinical trial data reliability in CNS studies
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
Integrated eCOA technology and rater training aim to reduce variability and strengthen ClinRO outcomes
The improved score reflects a stronger ESG profile for the Ahmedabad-based drugmaker
The reports will now be shared with relevant ministries and departments as a guidance framework
The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology
The study focused on patients without actionable genomic alterations whose disease had progressed after prior immunotherapy and platinum-based chemotherapy
The launch of the study was on the occasion of the International Day of Persons with Disabilities
The results demonstrated meaningful reductions in the severity of involuntary movements and notable improvements in patient-reported quality of life
Building on the Merck Foundation’s longstanding commitment to advancing access to high-quality health care, new national initiative supports grants to 11 organizations across the country
Second positive Phase III trial of AstraZeneca and Daiichi Sankyo’s Enhertu in HER2-positive early breast cancer reinforces its potential to become a foundational treatment option in curative-intent setting
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
Subscribe To Our Newsletter & Stay Updated
